32 min listen
Season 7, Episode 2: Drug-Induced Alopecia Areata
Season 7, Episode 2: Drug-Induced Alopecia Areata
ratings:
Length:
8 minutes
Released:
Apr 28, 2024
Format:
Podcast episode
Description
This episode is dedicated to a fascinating subject – drug-induced alopecia areata. In addition to genetic factors, alopecia areata is also influenced by environmental factors such as infections and medications. In this episode, Dr Donovan highlights two studies: “A Cross-Sectional Analysis of Medications Used by Patients Reporting Alopecia Areata on the FDA Adverse Events Reporting System” by Ravapati et al and “Drug-Induced Alopecia Areata: A Systematic Review” by Ezemma et al. These studies present an intensive exploration of drugs possibly causing alopecia areata.
Studies show that monoclonal antibodies are common culprits, and reports of drug-induced alopecia areata are rising every over time.
Surprisingly, it has been observed that the onset of drug-induced alopecia areata could be delayed by as much as a year. Also, patients who discontinued the alleged drug stimulating alopecia areata experienced regrowth of hair, while those who didn't, failed unless treated.
Email is info@donovanhairacademy.com or visit our website www.donovanhairacademy.com.
Thank you all for joining. See you next week!
Studies show that monoclonal antibodies are common culprits, and reports of drug-induced alopecia areata are rising every over time.
Surprisingly, it has been observed that the onset of drug-induced alopecia areata could be delayed by as much as a year. Also, patients who discontinued the alleged drug stimulating alopecia areata experienced regrowth of hair, while those who didn't, failed unless treated.
Email is info@donovanhairacademy.com or visit our website www.donovanhairacademy.com.
Thank you all for joining. See you next week!
Released:
Apr 28, 2024
Format:
Podcast episode
Titles in the series (62)
Season 1 Episode 1 (Androgenetic Alopecia and Alopecia Areata): REFERENCED STUDIES FOR ANDROGENETIC ALOPECIA Silva et al (starts at 1:10). Randomized clinical trial of low-dose oral minoxidil for the treatment of female pattern hair Loss: 0.25 mg versus 1 mg. Journal of the American Academy of Dermatology; Online Ja... by Evidence Based Hair